Cellulim is a Dutch/UAE biotechnology company focused on pluripotent stem cells and technology for drug discovery research, toxicity testing and regenerative medicine, Cellulim aims to work globally with industry and academia, platform providers and end users to develop the next generation of advanced stem cell products and technologies. The company leverages a deep experience in stem cell handling, scale up and differentiation into mature and functional human cells. The company is first in the world to bring to the market the embryoid model for use as drug discovery and personalised medicine tool. This embryoid technology platform offers a path to tools and regenerative medicine discoveries of the future. Cellulim will be located in the state of the art facility in Dubai, UAE. The laboratory is prepared to meet the EU and US guidelines for current Good Manufacturing Practice (cGMP).
TOOLS OF TODAY, AND THE FUTURE
Cellulim has driven innovation in stem cell research through to commercial opportunities since 2019. From the epiblast model to leveraging exiting innovations. Cellulim can offer you a doorway into discoveries of the future.
UAE – Dubai
Adres: 2nd floor, Laboratory Complex,
Office SD2-239, Al Barsha
P.O.Box: 500767, Dubai
Telephone No: 00971 58 561 9813
Netherlands – Amsterdam